New research from Rutgers University–Camden reveals a significant relationship between dietary protein intake and liver cancer progression in individuals with compromised liver function. The study, published in Science Advances, demonstrates how reducing protein consumption may help slow tumor growth by addressing metabolic imbalances in damaged livers.
With liver cancer affecting over 42,000 Americans annually and showing a five-year survival rate of just 22%, finding accessible prevention strategies remains critical. The research team led by Dr. Wei-Xing Zong at Rutgers Cancer Institute investigated why patients with liver dysfunction face higher cancer risks, focusing on ammonia metabolism as a key factor.
Have questions about liver health management? Consult your healthcare provider before making dietary changes.
Healthy livers convert protein-derived ammonia into harmless urea for excretion. When liver damage occurs – from conditions like fatty liver disease (affecting 1 in 4 U.S. adults), viral hepatitis, or alcohol-related cirrhosis – this detoxification process falters. The Rutgers study identified three critical mechanisms:
Researchers used genetically modified mice with disabled ammonia-processing enzymes to simulate human liver dysfunction. These animals developed:
When the team reduced dietary protein in these mice, tumor growth slowed dramatically and survival rates improved.
While the study doesn’t suggest universal protein restriction, it highlights specific considerations for different populations:
| Population | Protein Intake Recommendation |
|---|---|
| Healthy liver function | Maintain standard protein intake |
| Early-stage liver disease | Monitor protein consumption |
| Advanced liver dysfunction | Consider protein reduction under medical supervision |
Dr. Zong emphasizes that any dietary modifications should be medically supervised: “Patients undergoing cancer treatment often need adequate protein to maintain muscle mass. The appropriate balance depends on individual liver function and cancer status.”
Interested in nutritional approaches to liver health? Discuss protein adjustment strategies with your healthcare team.
The Rutgers team plans to investigate:
This research exemplifies Rutgers University–Camden’s commitment to translational science that addresses pressing public health challenges in the USA and globally.
Want to stay updated on liver cancer research? Follow Rutgers Cancer Institute’s ongoing studies for the latest developments.
This Rutgers University–Camden study provides valuable insights into how simple dietary adjustments might complement traditional liver cancer treatments. For the millions of Americans with fatty liver disease and other hepatic conditions, these findings offer a potential pathway to reduce cancer risk through targeted nutritional approaches.
As research continues to evolve, maintaining open communication with healthcare providers about dietary choices remains crucial for those managing liver health concerns.